Education and Training
- Fellow in Pulmonary Medicine, Medicine, Duke University, 2008 - 2009
- Resident, Medicine, Duke University, 2005 - 2008
- M.D., University of Colorado School of Medicine, 2005
Todd, JL, Neely, ML, Finlen Copeland, CA, Frankel, CW, Reynolds, JM, and Palmer, SM. "Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction." The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation 38, no. 2 (February 2019): 184-193.
Palmer, SM, Snyder, L, Todd, JL, Soule, B, Christian, R, Anstrom, K, Luo, Y, Gagnon, R, and Rosen, G. "Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis." Chest 154, no. 5 (November 2018): 1061-1069.
Messina, JA, Wolfe, CR, Hemmersbach-Miller, M, Milano, C, Todd, JL, Reynolds, J, Alexander, BD, Schell, WA, Cuomo, CA, and Perfect, JR. "Genomic characterization of recurrent mold infections in thoracic transplant recipients." Transplant Infectious Disease : an Official Journal of the Transplantation Society 20, no. 5 (October 2018): e12935-null.
Riley, IL, Boulware, LE, Sun, J-L, Chiswell, K, Que, LG, Kraft, M, Todd, JL, Palmer, SM, and Anderson, ML. "Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.gov." Clinical Trials (London, England) 15, no. 1 (February 2018): 87-94.
Petrovski, S, Todd, JL, Durheim, MT, Wang, Q, Chien, JW, Kelly, FL, Frankel, C, Mebane, CM, Ren, Z, Bridgers, J, Urban, TJ, Malone, CD, Finlen Copeland, A, Brinkley, C, Allen, AS, O'Riordan, T, McHutchison, JG, Palmer, SM, and Goldstein, DB. "An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis." American Journal of Respiratory and Critical Care Medicine 196, no. 1 (July 2017): 82-93.
Todd, JL, and Palmer, SM. "Danger signals in regulating the immune response to solid organ transplantation." The Journal of Clinical Investigation 127, no. 7 (June 2017): 2464-2472. (Review)
DerHovanessian, A, Todd, JL, Zhang, A, Li, N, Mayalall, A, Finlen Copeland, CA, Shino, M, Pavlisko, EN, Wallace, WD, Gregson, A, Ross, DJ, Saggar, R, Lynch, JP, Belperio, J, Snyder, LD, Palmer, SM, and Weigt, SS. "Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients." Annals of the American Thoracic Society 13, no. 5 (May 2016): 627-635.
Durheim, M, Wojdyla, D, Green, C, Keshavjee, S, McCurry, K, Lidor, A, Davis, R, Palmer, S, and Todd, J. "Evaluation of an FVC-Based Definition of Restrictive Chronic Lung Allograft Dysfunction (CLAD) in a Multi-Center Cohort." April 2016.
Todd, J, Finlen Copeland, C, Neely, M, and Palmer, S. "FVC and FEV1 Decline in Chronic Lung Allograft Dysfunction (CLAD) Phenotypes." April 2016.
O'Brien, EC, Shrader, P, Durheim, MT, Snyder, LD, Todd, JL, Gamerman, V, Anstrom, KJ, Belperio, JA, Culver, DA, De Andrade, JAM, Roman, J, Whelan, TPM, Conoscenti, CS, and Palmer, SM. "Disease Severity And Quality Of Life In Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients." 2016.